The Board of Directors of Celltrion, Inc. has authorized a buyback plan on October 25, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
185,100.00 KRW | -0.22% | +2.32% | -1.28% |
01-09 | Celltrion to Unveil Drug Development Plans at JP Morgan Conference | MT |
12-27 | Celltrion, Inc. announces an Equity Buyback for 546,747 shares. | CI |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- A068270 Stock
- News Celltrion, Inc.
- Celltrion, Inc. authorizes a Buyback Plan.